- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About NextCure Inc
Nextcure Inc. is a clinical-stage biopharmaceutical company, which is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases. The Company uses its functional integrated nextcure discovery in immune oncology (FIND-IO) technology to functional screening approaches for the identification of targets from multiple therapeutic areas, including autoimmunity and neurology, enabling immunomedicine to treat unmet medical needs. Its product pipelines include NC318, a immunotherapeutic against a immunomodulatory target found on a restricted set of myeloid and tumor cells, and NC410, a immunomedicine designed to block an immune regulator expressed on T cells and suppressive antigen-presenting cell populations, including dendritic cell subpopulations.
| Popular Stocks | Price | Change |
|---|---|---|
|
C
|
$8.82
 20.85%
|
20.85% |
|
$2.27
3.18%
|
3.18% |
|
$134.16
0.17%
|
0.17% |
|
$36.09
4.21%
|
4.21% |
|
$39.15
 0.08%
|
0.08% |
|
$43.84
2.12%
|
2.12% |
|
$38.57
1.58%
|
1.58% |
|
$27.24
5%
|
5% |
|
$13.39
1.83%
|
1.83% |
|
$82.15
0.58%
|
0.58% |
News
Connect
People who are active on baraka tribe community
Stock Analysis
